Literature DB >> 25871629

Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.

Jasmien Orije1, Firat Kara2, Caroline Guglielmetti1, Jelle Praet1, Annemie Van der Linden1, Peter Ponsaerts3, Marleen Verhoye1.   

Abstract

Non-invasive measures of well-known pathological hallmarks of multiple sclerosis (MS) such as demyelination, inflammation and axonal injury would serve as useful markers to monitor disease progression and evaluate potential therapies. To this end, in vivo localized proton magnetic resonance spectroscopy ((1)H-MRS) provides a powerful means to monitor metabolic changes in the brain and may be sensitive to these pathological hallmarks. In our study, we used the cuprizone mouse model to study pathological features of MS, such as inflammation, de- and remyelination, in a highly reproducible manner. C57BL/6J mice were challenged with a 0.2% cuprizone diet for 6-weeks to induce demyelination, thereafter the mice were put on a cuprizone free diet for another 6weeks to induce spontaneous remyelination. We employed in vivo (1)H-MRS to longitudinally monitor metabolic changes in the corpus callosum of cuprizone-fed mice during the demyelination (weeks 4 and 6) and spontaneous remyelination (week 12) phases. The MRS spectra were quantified with LCModel and since the total creatine (tCr) levels did not change over time or between groups, metabolite concentrations were expressed as ratios relative to tCr. After 4 and 6weeks of cuprizone treatment a significant increase in taurine/tCr and a significant reduction in total N-acetylaspartate/tCr, total choline-containing compounds/tCr and glutamate/tCr could be observed compared to mice under normal diet. At week 12, when almost full remyelination was established, no statistically significant metabolic differences were present between the control and cuprizone group. Our results suggest that these metabolic changes may represent sensitive markers for cuprizone induced demyelination, axonal injury and inflammation. To the best of our knowledge, this is the first longitudinal in vivo (1)H-MRS study that monitored biochemical changes in the corpus callosum of cuprizone fed mice.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cuprizone mouse model; Demyelination; Longitudinal; Multiple sclerosis; Proton magnetic resonance spectroscopy; Remyelination

Mesh:

Substances:

Year:  2015        PMID: 25871629     DOI: 10.1016/j.neuroimage.2015.04.012

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  14 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Integrity of White Matter is Compromised in Mice with Hyaluronan Deficiency.

Authors:  Ang D Sherpa; David N Guilfoyle; Aditi A Naik; Jasmina Isakovic; Fumitoshi Irie; Yu Yamaguchi; Jan Hrabe; Chiye Aoki; Sabina Hrabetova
Journal:  Neurochem Res       Date:  2019-06-07       Impact factor: 3.996

3.  Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis.

Authors:  Fei Gao; Xuntao Yin; Richard A E Edden; Alan C Evans; Junhai Xu; Guanmei Cao; Honghao Li; Muwei Li; Bin Zhao; Jian Wang; Guangbin Wang
Journal:  Hippocampus       Date:  2018-11       Impact factor: 3.899

Review 4.  Remyelinating Pharmacotherapies in Multiple Sclerosis.

Authors:  Riley M Bove; Ari J Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 5.  The mechanistic target of rapamycin as a regulator of metabolic function in oligodendroglia during remyelination.

Authors:  Marie L Mather; Marisa A Jeffries; Teresa L Wood
Journal:  Curr Opin Pharmacol       Date:  2022-03-01       Impact factor: 5.547

6.  Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model.

Authors:  Soheila Madadi; Elham Shiri; Parichehr Pasbakhsh; Fatemeh Tahmasebi; Shokoofeh Kazemzadeh; Kazem Zibara; Iraj Ragerdi Kashani
Journal:  Mol Neurobiol       Date:  2022-09-29       Impact factor: 5.682

7.  Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.

Authors:  C Guglielmetti; J Veraart; E Roelant; Z Mai; J Daans; J Van Audekerke; M Naeyaert; G Vanhoutte; R Delgado Y Palacios; J Praet; E Fieremans; P Ponsaerts; J Sijbers; A Van der Linden; M Verhoye
Journal:  Neuroimage       Date:  2015-10-23       Impact factor: 6.556

8.  Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model.

Authors:  Caroline Guglielmetti; Chloé Najac; Alessandro Didonna; Annemie Van der Linden; Sabrina M Ronen; Myriam M Chaumeil
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

9.  Long-term ovarian hormone deprivation alters functional connectivity, brain neurochemical profile and white matter integrity in the Tg2576 amyloid mouse model of Alzheimer's disease.

Authors:  Firat Kara; Michael E Belloy; Rick Voncken; Zahra Sarwari; Yadav Garima; Cynthia Anckaerts; An Langbeen; Valerie Leysen; Disha Shah; Jules Jacobs; Julie Hamaide; Peter Bols; Johan Van Audekerke; Jasmijn Daans; Caroline Guglielmetti; Kejal Kantarci; Vincent Prevot; Steffen Roßner; Peter Ponsaerts; Annemie Van der Linden; Marleen Verhoye
Journal:  Neurobiol Aging       Date:  2021-02-22       Impact factor: 4.673

10.  In vivo tensor-valued diffusion MRI of focal demyelination in white and deep grey matter of rodents.

Authors:  Yi He; Susana Aznar; Hartwig R Siebner; Tim B Dyrby
Journal:  Neuroimage Clin       Date:  2021-04-15       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.